Experienced in Juvenile Angiofibroma

Dr. Mohammad S. Siddiqui

General Surgery
Commonwealth Physician Network LLC
575 N River St, 
Wilkes Barre, PA 
Experienced in Juvenile Angiofibroma
Commonwealth Physician Network LLC
575 N River St, 
Wilkes Barre, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mohammad Siddiqui is a General Surgeon in Wilkes Barre, Pennsylvania. Dr. Siddiqui is rated as an Experienced provider by MediFind in the treatment of Juvenile Angiofibroma. His top areas of expertise are Liver Failure, Obesity, Gallbladder Disease, Liver Transplant, and Gastrostomy.

His clinical research consists of co-authoring 189 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
General Surgery
Licenses
Surgery in PA
Hospital Affiliations
Regional Hospital Of Scranton
Wilkes-Barre General Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 6 Less Insurance Carriers -

Locations

COMMONWEALTH PHYSICIAN NETWORK LLC
575 N River St, Wilkes Barre, PA 18702
Other Locations
COMMONWEALTH PHYSICIAN NETWORK LLC
200 S River St, Plains, PA 18705
COMMONWEALTH PHYSICIAN NETWORK LLC
746 Jefferson Ave, Scranton, PA 18510
COMMONWEALTH PHYSICIAN NETWORK LLC
4 E Main St, Nanticoke, PA 18634

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
Clinical Study of the BreathID® System to Train the Algorithm for the ¹³C-Octanoate Breath Test With or Without the ¹³C-Methacetin Breath Test (OBT and MBT Respectively) for Correlation With Histological Findings Associated With Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases
Clinical Study of the BreathID® System to Train the Algorithm for the ¹³C-Octanoate Breath Test With or Without the ¹³C-Methacetin Breath Test (OBT and MBT Respectively) for Correlation With Histological Findings Associated With Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases
Enrollment Status: Completed
Publish Date: December 20, 2022
Intervention Type: Device
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Enrollment Status: Completed
Publish Date: May 02, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials
Similar Doctors
Matthew Souder
Distinguished in Juvenile Angiofibroma
Dr. Matthew Souder
General Surgery
Distinguished in Juvenile Angiofibroma
Dr. Matthew Souder
General Surgery

Geisinger Medical Center - General Surgery

100 North Academy Avenue, 
Danville, PA 
 (43.4 miles away)
800-275-6401
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Matthew Souder, MD, is a board-certified general surgeon. He earned his medical degree from St. George’s University School of Medicine in Grenada. After medical school, he completed a residency in general surgery at PinnacleHealth in Harrisburg.|During his undergraduate training, Dr. Souder completed several research projects on fetal alcohol syndrome and other topics.|He’s a native of Lewisburg. Dr. Souder is rated as an Advanced provider by MediFind in the treatment of Juvenile Angiofibroma. His top areas of expertise are Juvenile Angiofibroma, Cellulitis, Gallstones, Choledocholithiasis, and Hernia Surgery.

Advanced in Juvenile Angiofibroma
Dr. Christian D. Tvetenstrand
General Surgery
Advanced in Juvenile Angiofibroma
Dr. Christian D. Tvetenstrand
General Surgery
30 Harrison St, Suite 320, 
Johnson City, NY 
 (59.4 miles away)
607-763-8205
Languages Spoken:
English
See accepted insurances

Christian Tvetenstrand is a General Surgeon in Johnson City, New York. Dr. Tvetenstrand is rated as a Distinguished provider by MediFind in the treatment of Juvenile Angiofibroma. His top areas of expertise are Hernia, Gallbladder Disease, Gallstones, Hernia Surgery, and Gastrostomy.

Advanced in Juvenile Angiofibroma
Dr. Margaret L. Riccardi
General Surgery
Advanced in Juvenile Angiofibroma
Dr. Margaret L. Riccardi
General Surgery

St Joseph Medical Group

2494 Bernville Rd, Suite 201, 
Reading, PA 
 (61.3 miles away)
610-378-2225
Experience:
10+ years
Languages Spoken:
English
See accepted insurances

Margaret Riccardi is a General Surgeon in Reading, Pennsylvania. Dr. Riccardi has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of Juvenile Angiofibroma. Her top areas of expertise are Hernia, Juvenile Angiofibroma, Acrospiroma, Colostomy, and Gallbladder Removal.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Siddiqui's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile